title: Systematic prevention of severe constipation induced by antipsychotic agents: A quasi-experimental study.
authors.affiliation: Centre Hospitalier de Versailles, Service de Psychiatrie de l'adulte, Le Chesnay, France.
authors.forename: Virginie
authors.initials: V
authors.lastname: Bulot
authors.affiliation: Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine, Paris, France; AP-HP, Hôpitaux Universitaires Paris Ouest, Service de Psychiatrie de l'adulte et du sujet âgé, Paris, France; Inserm, U894, Centre Psychiatrie et Neurosciences, Paris, France. Electronic address: cedric.lemogne@aphp.fr.
authors.forename: Cédric
authors.initials: C
authors.lastname: Lemogne
authors.affiliation: Centre Hospitalier de Versailles, Service de Pharmacie, Le Chesnay, France.
authors.forename: Nicaise
authors.initials: N
authors.lastname: Nebot
authors.affiliation: Centre Hospitalier de Versailles, Service d'Hépato-gastro-entérologie, Le Chesnay, France.
authors.forename: Hugues
authors.initials: H
authors.lastname: Blondon
authors.affiliation: Centre Hospitalier de Versailles, Service de Psychiatrie de l'adulte, Le Chesnay, France; Centres Experts, Fondation Fondamental, Créteil, France; Université Versailles Saint-Quentin, UFR des sciences de la santé, Montigny-le-Bretonneux, France.
authors.forename: Paul
authors.initials: P
authors.lastname: Roux
mesh_terms: D000285:Administration, Rectal; D014150:Antipsychotic Agents / Q000009:adverse effects*; D003006:Clopenthixol / Q000009:adverse effects; D003024:Clozapine / Q000009:adverse effects; D003248:Constipation / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology / Q000517:prevention & control*; D004334:Drug Administration Schedule; D016903:Drug Monitoring; D004359:Drug Therapy, Combination / Q000009:adverse effects; D006801:Humans; D007362:Intensive Care Units; D054368:Laxatives / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008728:Methotrimeprazine / Q000009:adverse effects; D053149:Plant Gums / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012720:Severity of Illness Index; D032361:Sterculia / Q000737:chemistry; D013501:Surface-Active Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D014150:Antipsychotic Agents; D054368:Laxatives; D053149:Plant Gums; D013501:Surface-Active Agents; D011092:Polyethylene Glycols; D003006:Clopenthixol; D008728:Methotrimeprazine; D003024:Clozapine